Filing Details
- Accession Number:
- 0001179110-13-011557
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-03 17:46:16
- Reporting Period:
- 2013-07-01
- Filing Date:
- 2013-07-03
- Accepted Time:
- 2013-07-03 17:46:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1327145 | L Robin Washington | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Svp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-07-01 | 10,000 | $27.07 | 37,130 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-07-01 | 5,000 | $23.60 | 42,130 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-07-01 | 3,000 | $24.91 | 45,130 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-07-01 | 4,800 | $23.76 | 49,930 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-07-01 | 11,550 | $19.09 | 61,480 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-07-01 | 11,250 | $24.30 | 72,730 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-01 | 43,100 | $51.97 | 29,630 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-07-01 | 2,500 | $52.65 | 27,130 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-07-01 | 11,550 | $0.00 | 11,550 | $19.09 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-07-01 | 5,000 | $0.00 | 5,000 | $23.60 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-07-01 | 4,800 | $0.00 | 4,800 | $23.76 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-07-01 | 11,250 | $0.00 | 11,250 | $24.30 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-07-01 | 3,000 | $0.00 | 3,000 | $24.91 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-07-01 | 10,000 | $0.00 | 10,000 | $27.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
80,850 | 2021-01-20 | No | 4 | M | Direct | |
15,000 | 2019-01-21 | No | 4 | M | Direct | |
33,600 | 2020-01-28 | No | 4 | M | Direct | |
123,750 | 2022-01-26 | No | 4 | M | Direct | |
15,000 | 2019-07-29 | No | 4 | M | Direct | |
0 | 2018-05-07 | No | 4 | M | Direct |
Footnotes
- The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- Sale prices reported for the transactions reported here range from $51.57 to $52.57. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $52.58 to $52.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.